A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...

Bill to pay for multi-cancer early detection screening test has bipartisan support, but just ran out of time last session.

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...

About the program: Project Equity is a 2021 initiative launched by the FDA's Oncology Center of Excellence to ensure that ...

Astra is due to pay Daiichi US$175 million in milestones after the US approval, the companies said. Enhertu is cleared in the ...

During Donald Trump's draconian first-week rollbacks, cancer research and other crucial medical projects have been paused ...

The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with ...

In his first Senate confirmation hearing to be secretary of the Department of Health and Human Services, Robert F. Kennedy Jr ...

On January 16, 2025, the Food and Drug Administration (FDA) issued an order banning FD&C Red No.3 in food and ingested drugs.1 Food and ingested ...

Last week, the Food and Drug Administration banned Red Dye No. 3 over cancer risks. Good.